Sepsis facts

Early recognition is critical for timely intervention1

Clarity in early assessment and intervention to help you stay ahead of sepsis6

Managing sepsis is time-sensitive.7,8 It is critically important that patients are diagnosed as soon as possible, and receive the appropriate intensive care.

Septic patients may present widely diverse hemodynamic profiles. Intermittent monitoring of critical and rapidly changing patient parameters provides insufficient information when determining volume responsiveness.

When every moment counts, access to advanced dynamic and flow-based hemodynamic parameters offers valuable insight to help you guide proactive volume administration decisions.6

Edwards Lifesciences advanced hemodynamic monitoring solutions can help you detect sepsis symptoms early, help guide treatment evaluation and comply with CMS/NQF bundle guidelines.6,10-12

Sepsis Bundle Guidelines Overview > View now Sepsis Bundle Guidelines Poster > Request a copy now

Hemodynamic monitoring solutions

Hemodynamic monitoring solutions to help assess patients individually and meet
CMS guidelines6, 10-12

Edwards offers advanced hemodynamic monitoring solutions that clinicians can tailor based on each patient's physiological needs to help proactively manage sepsis, severe sepsis and septic shock.6

Finger cuff

Noninvasive ClearSight finder cuff

SV, SVV, SVR, CO, cBP

The ClearSight finger cuff can be used to measure flow-based parameters continuously prior to, during, and after the fluid administration portion of the 3-hour CMS sepsis bundle. The ClearSight finger cuff connects quickly and noninvasively to a broad patient population, including the elderly or obese.9, 13-14 It can be used to test fluid responsiveness with a fluid challenge and passive leg raise for patients not mechanically ventilated. Continuous blood pressure, CO and SV provide actionable information about sensitive changes in preload.9

FloTrac

Minimally-Invasive FloTrac sensor

SVV, SVR, CCO

The FloTrac system can be used to measure flow-based parameters continuously prior to, during, and after the fluid administration portion of the 3-hour CMS sepsis bundle. The FloTrac system is minimally-invasive and connects to any existing arterial catheter to escalate the level of continuous monitoring as patient acuity changes. Continuous monitoring of CO and SV provides actionable information about sensitive changes in preload.9

Oximetry

Edwards Oximetry Central Venous Catheter (CVC)

ScvO2, CVP

The Edwards oximetry central venous catheter meets the CMS core measures recommendation for placing a central line when giving vasopressors.15-16 You can meet reassessment requirements with one device by utilizing Edwards oximetry CVC for measuring continuous ScvO2 and CVP. The Edwards oximetry CVC provides continuous ScvO2, an early indicator of compromised or inadequate oxygen delivery demonstrated to reveal critical changes earlier than vital signs alone, enabling you to respond sooner.17-21

Make a difference

Your hospital cannot afford to wait

The sepsis bundle guidelines as presented, were published by CMS on August 4, 2014 and are presented for informational purposes only. This information does not constitute reimbursement or medical advice. Edwards makes no representation or warranty regarding this information or its completeness, accuracy or timeliness. It is not intended to make a recommendation regarding clinical practice. Laws, regulations, and payer policies concerning reimbursement are complex and change frequently; service providers are responsible for all decisions relating to clinical services, coding and reimbursement submissions. Accordingly, Edwards strongly recommends consultation with CMS, payers, reimbursement specialists and/or legal counsel regarding guidelines, coding, coverage, and reimbursement matters.

Resources
Take action

Contact a sales representative

References
  1. ACEP Expert Panel on Sepsis. DART evidence-driven tool guide.
  2. Statistics, National Center For Health. NCHS Data Brief, Number 62, June 2011 (n.d.): n. pag. www.CDC.gov . Centers for Disease Control, June 2011. Web. 6 Apr. 2016.
  3. Liu, Vincent, Gabriel J. Escobar, John D. Greene, Jay Soule, Alan Whippy, Derek C. Angus, and Theodore J. Iwashyna. "Hospital Deaths in Patients With Sepsis From 2 Independent Cohorts." Jama 312.1 (2014): 90. Web.
  4. Statistics, National Center For Health. NCHS Data Brief, Number 62, June 2011 (n.d.): n. pag. www.CDC.gov. Centers for Disease Control, June 2011. Web. 6 Apr. 2016.
  5. World Sepsis Day Sepsis Fact Sheet, 2015.
  6. Marik, Paul E., Xavier Monnet, and Jean-Louis Teboul. “Hemodynamic Parameters to Guide Fluid Therapy.” Ann Intensive Care Annals of Intensive Care 1.1 (2011):1. Web.
  7. Martin, Greg S. “Sepsis, Severe Sepsis and Septic Shock: Changes in Incidence, Pathogens and Outcomes.” Expert review of anti-infective therapy 10.6 (2012): 701–706. PMC. Web. 12 July 2016.
  8. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006.
  9. Truijen et al. Noninvasive Continuous Hemodynamic Monitoring. Journal of Clinical Monitoring and Computing. 2012.
  10. Operators Manual EV1000_157811A5.
  11. EV1000 Operators Manual (S-0351).
  12. GOV: Sepsis Bundle Project - SEP1.
  13. Eeftinck Schattenkerk D, et al. Nexfin Noninvasive Continuous Blood Pressure Validated Against Riva-Rocci/Korotkoff. American Journal of Hypertension 2009; 22(4):378-383.
  14. Maguire S, et al. Respiratory Variation in Pulse Pressure and Plethysmographic Waveforms: Intraoperative Applicability in a North American Academic Center. Anesthesia & Analgesia 2011;112:94-6.
  15. Dougherty L. Central venous access devices. Nurs Stand. 2000;14(43):45–50. [PubMed]
  16. Moureau N, Poole S, Murdock MA, Gray SM, Semba CP. Central venous catheters in home infusion care: outcomes analysis in 50,470 patients. J Vasc Interv Radiol. 2002;13(10):1009–16. [PubMed]
  17. Reinhart K, et al. Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill. Intensive Care Med. 2004;30(8):1572-8.
  18. Rivers EP, et al. Central venous oxygen saturation monitoring in the critically ill patient. Curr Opin Crit Care. 2001;7(3):204-11.
  19. Ingelmo P, et al. Importance of monitoring in high risk surgical patients. Minerva Anestesiol. 2002;68(4):226-30.
  20. Scalea, TM, et al. Central venous oxygen saturation: a useful clinical tool in trauma patients. J Trauma 1990;30(12):1539-43.
  21. Ander, DS, et al. Undetected cardiogenic shock in patients with congestive heart failure presenting to the emergency department. Am J Cardiol 1998;82(7):888-91.
  22. Chen, Caroline, and Doni Bloomfield. "Deadly Infections Drive Billions in Hospital Bills to Medicare." Bloomberg.com . Bloomberg, 15 June 2015. Web. 06 Apr. 2016
  23. Statistics, National Center For Health. NCHS Data Brief, Number 62, June 2011 (n.d.): n. pag. www.CDC.gov . Centers for Disease Control, June 2011. Web. 6 Apr. 2016.
  24. Statistics, National Center For Health. NCHS Data Brief, Number 62, June 2011 (n.d.): n. pag. www.CDC.gov . Centers for Disease Control, June 2011. Web. 6 Apr. 2016.
  25. Report to Congress: Medicare and the Health Care Delivery System, June 2015.

Please update your browser

Please update to a current version of your preferred browser, this site will perform effectively on the following:

Unable to update your browser?

If you are on a computer, that is maintained by an admin and you cannot install a new browser, ask your admin about it. If you can't change your browser because of compatibility issues, think about installing a second browser for browsing and keep this old one for compatibility